Segueix
Urvashi Dhiman
Urvashi Dhiman
PhD Scholar CSIR-Indian Institute of Integrative Medicine
Correu electrònic verificat a acsir.res.in
Títol
Citada per
Citada per
Any
Docking of fda approved drugs targeting nsp-16, n-protein and main protease of sars-cov-2 as dual inhibitors
R Yadav, RD Parihar, U Dhiman, P Dhamija, SK Upadhyay, M Imran, ...
Biointerface Res. Appl. Chem 11 (3), 9848-9861, 2020
212020
Heterorhabditis and Photorhabdus Symbiosis: A Natural Mine of Bioactive Compounds
RD Parihar, U Dhiman, A Bhushan, PK Gupta, P Gupta
Frontiers in microbiology 13, 790339, 2022
112022
In silico analysis of tumour necrosis factor (TNF) in Homo sapiens
S Rana, U Dhiman, RD Parihar, SK Upadhyay
Biointerface Res Appl Chem 12 (1), 781-794, 2021
82021
Virtual screening of potential drug molecules against Covid-19 targets: A drug repurposing approach
R Yadav, U Dhiman, RD Parihar, SK Upadhyay
Lett. Appl. NanoBioScience 11 (1), 2965-2980, 2021
52021
Comparative In Silico Analysis of Randomly Selected Heat Shock Proteins in Caenorhabditis elegans and Photorhabdus temperata
U Dhiman, RD Parihar, S Rana, SK Upadhyay, V Kumar
Biointerface Research in Applied Chemistry 11, 11418-11430, 2020
32020
Trilliumosides A-B, two novel steroidal saponins isolated from Rhizomes of Trillium govanianum as potent anticancer agents targeting apoptosis in A-549 cancer …
BA Lone, M Tabassum, A Bhushan, U Dhiman, D Rani, PN Gupta, ...
bioRxiv, 2023.04. 17.537170, 2023
22023
Trilliumosides K and L, two novel steroidal saponins from rhizomes of Trillium govanianum, as potent anti-cancer agents targeting apoptosis in the A-549 cancer …
BA Lone, M Tabassum, A Bhushan, D Rani, U Dhiman, A Ahmad, HA Mir, ...
Frontiers in Chemistry 11, 1306271, 2023
12023
En aquests moments el sistema no pot dur a terme l'operació. Torneu-ho a provar més tard.
Articles 1–7